Acute myeloid leukemia is primarily a disease of older people with the average age of first diagnosis at 68 years old. Older patients may face many barriers to accessing care due to social determinants of health, including comorbidities, financial/insurance obstacles, transportation barriers, and inadequate caregiver support, which contribute to disparities and inequities in treatment and access.
ACCC’s Addressing Disparities in Access to Care for Acute Myeloid Leukemia program explores the current challenges in care coordination and therapy options for patients with acute myeloid leukemia and highlights strategies and best practices to improve outcomes for these patients.
For more information about this project, please contact the ACCC Provider Education Department.
September is Blood Cancer Awareness month, an opportunity to spotlight the broad category of diseases that include leukemia, lymphoma, plasma cell neoplasms, myelodysplastic syndromes, and myeloproliferative neoplasms.
Evaluate recommendations on improving clinical trial diversity among patients with acute myeloid leukemia.